Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Radiology quiz case 1. Iodine 131–induced sialadenitis.

Choi N, Schularick N, Diggelmann H, Smoker W, Hoffman H.

Arch Otolaryngol Head Neck Surg. 2012 Jun;138(6):597-8. doi: 10.1001/archoto.2012.429. No abstract available.

PMID:
22710514
2.

Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication.

Allweiss P, Braunstein GD, Katz A, Waxman A.

J Nucl Med. 1984 Jul;25(7):755-8.

4.

Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa).

Gonzalez ME, Muttikkal TJ, Rehm PK.

J Radiol Case Rep. 2015 Jun 30;9(6):44-9. doi: 10.3941/jrcr.v9i6.2220. eCollection 2015 Jun.

5.

Effects of Salivary Secretion Stimulation on the Treatment of Chronic Radioactive Iodine-Induced Sialadenitis.

Choi JS, Hong SB, Hyun IY, Lim JY, Kim YM.

Thyroid. 2015 Jul;25(7):839-45. doi: 10.1089/thy.2014.0525. Epub 2015 Apr 20.

PMID:
25809840
6.

Sialadenitis following iodine-131 therapy for thyroid carcinoma.

[No authors listed]

J Nucl Med. 1985 Jul;26(7):816-7. No abstract available.

7.

Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis.

Wu CB, Xi H, Zhou Q, Zhang LM.

J Oral Maxillofac Surg. 2015 Mar;73(3):475-81. doi: 10.1016/j.joms.2014.09.025. Epub 2014 Oct 12.

PMID:
25544300
8.

Iodide mumps: a case report of complicated radioactive iodine causing sialadenitis.

Lei L, Velasco O, Nobay F.

Am J Emerg Med. 2012 Mar;30(3):512.e5-6. doi: 10.1016/j.ajem.2010.12.037. Epub 2011 Feb 26.

PMID:
21354757
9.

Dramatic parotid uptake of I-131 on a diagnostic whole-body scan.

Carlisle MR, McDougall IR.

Clin Nucl Med. 2000 Nov;25(11):895-7.

PMID:
11079586
10.
11.

Persistent sialadenitis after radioactive iodine therapy: report of two cases.

Mandel SJ, Mandel L.

J Oral Maxillofac Surg. 1999 Jun;57(6):738-41. No abstract available.

PMID:
10368102
12.

Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.

Lee SM, Lee JW, Kim SY, Han SW, Bae WK.

Ann Nucl Med. 2013 Oct;27(8):700-9. doi: 10.1007/s12149-013-0735-3. Epub 2013 Aug 7.

PMID:
23921836
13.

Sialadenitis mimicking metastatic thyroid carcinoma.

Kolla IS, Alazraki NP, Watts NB.

Clin Nucl Med. 1989 Aug;14(8):564-6.

PMID:
2805535
14.

Unusual patterns of I-131 accumulation.

Ozguven M, Ilgan S, Karacalioglu AO, Arslan N, Ozturk E.

Clin Nucl Med. 2004 Nov;29(11):738-40. No abstract available.

PMID:
15483496
15.

Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.

Almeida JP, Sanabria AE, Lima EN, Kowalski LP.

Head Neck. 2011 May;33(5):686-90. doi: 10.1002/hed.21520. Epub 2010 Nov 10.

PMID:
21484917
16.
17.

Sialadenitis following radioiodine therapy - a new diagnostic and treatment modality.

Nahlieli O, Nazarian Y.

Oral Dis. 2006 Sep;12(5):476-9.

PMID:
16910918
18.

Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.

Bricout P, Kibler RS.

J Can Assoc Radiol. 1973 Dec;24(4):323-7. No abstract available.

PMID:
4773908
19.

Salivary gland injury resulting from exposure to radioactive iodine: case reports.

Mandel L, Liu F.

J Am Dent Assoc. 2007 Dec;138(12):1582-7.

PMID:
18056102
20.

Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Brenner W, Kröger S, Buchert R, Bleckmann C, Mester J, Henze E, Clausen M.

Strahlenther Onkol. 1999 Nov;175 Suppl 4:6-12.

PMID:
10584133

Supplemental Content

Support Center